ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

VERV Verve Therapeutics Inc

5.54
0.00 (0.00%)
2024年5月22日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Verve Therapeutics Inc VERV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 5.54 09:00:00
始値 安値 高値 終値 前日終値
5.54
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0820:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0820:15EDGAR2Form 8-K - Current report
2024/5/0820:00GLOBEVerve Therapeutics Announces Pipeline Progress and Reports..
2024/5/0720:00GLOBEVerve Therapeutics Announces Dosing of First Patient in..
2024/5/0405:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
2024/4/0220:00GLOBEVerve Therapeutics Announces Updates on its PCSK9 Program
2024/3/2905:51GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
2024/3/0206:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
2024/2/2722:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2722:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2721:45EDGAR2Form 8-K - Current report
2024/2/2721:30GLOBEVerve Therapeutics Provides Pipeline Progress and Reports..
2024/2/1706:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0120:30GLOBEVerve Therapeutics to Participate in the Guggenheim..
2024/1/0220:30GLOBEVerve Therapeutics to Present at the 42nd Annual J.P. Morgan..
2023/12/0206:00GLOBEVerve Therapeutics Announces Closing of Public Offering of..
2023/11/3006:54EDGAR2Form 8-K - Current report
2023/11/3006:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2920:47DJNVerve Therapeutics Shares Tumble Premarket After Stock Sales
2023/11/2912:37GLOBEVerve Therapeutics Announces Pricing of Public Offering of..
2023/11/2906:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2906:01GLOBEVerve Therapeutics Announces Proposed Public Offering of..
2023/11/1320:34EDGAR2Form 8-K - Current report
2023/11/1305:30GLOBEVerve Therapeutics Announces Interim Data for VERVE-101..
2023/11/0721:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:00EDGAR2Form 8-K - Current report
2023/11/0720:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
2023/10/3119:59DJNBeam Therapeutics to Sell Rights in Verve Licensing Deal to..
2023/10/3119:01GLOBEVerve and Lilly Relationship Expands to Include Verve’s In..
2023/10/2320:22DJNVerve Therapeutics Gets Clinical Hold For VERVE-101 Lifted..
2023/10/2319:41EDGAR2Form 8-K - Current report
2023/10/2319:30GLOBEVerve Therapeutics Announces Clearance of Investigational..
2023/9/2619:30GLOBEVerve to Present Interim Data from the heart-1 Phase 1b..
2023/9/2205:05GLOBEVerve Therapeutics to Participate in the 2023 Cantor Global..
2023/9/1819:30GLOBEVerve Expands Leadership Team with Appointment of Frederick..
2023/8/1020:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:00EDGAR2Form 8-K - Current report
2023/8/1019:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
2023/8/0319:30GLOBEVerve Therapeutics to Present at the Canaccord 43rd Annual..
2023/6/1520:16DJNVerve Therapeutics Strikes Gene Editing Deal With Eli Lilly
2023/6/1519:30GLOBEVerve Establishes Global Collaboration with Lilly to Advance..
2023/6/0119:30GLOBEVerve Therapeutics to Participate in the 2023 Jefferies..
2023/5/2319:30GLOBEVerve Therapeutics to Participate in the Stifel 2023..

最近閲覧した銘柄

Delayed Upgrade Clock